Literature DB >> 16740311

Neutral and cationic mononuclear copper(II) complexes with enrofloxacin: structure and biological activity.

Eleni K Efthimiadou1, Yiannis Sanakis, Maria Katsarou, Catherine P Raptopoulou, Alexandra Karaliota, Nikos Katsaros, George Psomas.   

Abstract

The mononuclear copper complexes with the quinolone antibacterial drug enrofloxacin (=Herx) in the presence or not of a nitrogen donor heterocyclic ligand 1,10-phenanthroline (=phen) and 2,2'-bipyridine (=bipy) have been prepared and characterized. Interaction of copper(II) with deprotonated enrofloxacin leads to the formation of the neutral complex Cu(erx)2(H2O), 1, while the presence of phen or bipy leads to the formation of a neutral or a cationic mononuclear complex, respectively. The crystal structures of (chloro)(1,10-phenanthroline)(enrofloxacinato)copper(II), 2, and (aqua)(2,2'-bipyridine)(enrofloxacinato)copper(II) chloride, 3, have been determined with X-ray crystallography. The complexes have been studied with X-band electron paramagnetic resonance in aqueous solutions at liquid helium temperature. The study of the interaction of the complexes with calf-thymus DNA has been performed with diverse spectroscopic techniques and has showed that all complexes are bound to DNA by the intercalative mode. The antimicrobial efficiency of the complexes has been tested on three different microorganisms and the available evidence supports that the best inhibition is provided by Cu(erx)2(H2O) (minimum inhibitory concentration=0.125 microg mL(-1)) against Escherichia coli and Pseudomonas aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740311     DOI: 10.1016/j.jinorgbio.2006.03.013

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  8 in total

1.  Organometallic rhenium tricarbonyl-enrofloxacin and -levofloxacin complexes: synthesis, albumin-binding, DNA-interaction and cell viability studies.

Authors:  Chaido-Christina Pagoni; Vasiliki-Styliani Xylouri; Georgios C Kaiafas; Marialena Lazou; Georgia Bompola; Evangelos Tsoukas; Lefkothea C Papadopoulou; George Psomas; Dionysia Papagiannopoulou
Journal:  J Biol Inorg Chem       Date:  2019-05-20       Impact factor: 3.358

2.  New insights into the translocation route of enrofloxacin and its metalloantibiotics.

Authors:  C Ribeiro; S C Lopes; P Gameiro
Journal:  J Membr Biol       Date:  2011-05-17       Impact factor: 1.843

3.  Synthesis, Characterization, and Antifungal Studies of Cr(III) Complex of Norfloxacin and Bipiridyl Ligand.

Authors:  Anamika Debnath; Firasat Hussain; Dhanraj T Masram
Journal:  Bioinorg Chem Appl       Date:  2014-09-03       Impact factor: 7.778

4.  Fluoroquinolone Metalloantibiotics: A Promising Approach against Methicillin-Resistant Staphylococcus aureus.

Authors:  Mariana Ferreira; Lucinda J Bessa; Carla F Sousa; Peter Eaton; Dafne Bongiorno; Stefania Stefani; Floriana Campanile; Paula Gameiro
Journal:  Int J Environ Res Public Health       Date:  2020-04-30       Impact factor: 3.390

Review 5.  Metal complexes of quinolone antibiotics and their applications: an update.

Authors:  Valentina Uivarosi
Journal:  Molecules       Date:  2013-09-11       Impact factor: 4.411

6.  Fluoroquinolone Metalloantibiotics to Bypass Antimicrobial Resistance Mechanisms: Decreased Permeation through Porins.

Authors:  Mariana Ferreira; Carla F Sousa; Paula Gameiro
Journal:  Membranes (Basel)       Date:  2020-12-22

7.  Solvent-driven structural topology involving energetically significant intra- and intermolecular chelate ring contacts and anticancer activities of Cu(ii) phenanthroline complexes involving benzoates: experimental and theoretical studies.

Authors:  Manjit K Bhattacharyya; Utpal Saha; Debajit Dutta; Amal Das; Akalesh K Verma; Antonio Frontera
Journal:  RSC Adv       Date:  2019-05-24       Impact factor: 4.036

8.  Coordination behavior of 3-ethoxycarbonyltetronic acid towards Cu(II) and Co(II) metal ions.

Authors:  Giorgos Athanasellis; Georgia Zahariou; Stefanos Kikionis; Olga Igglessi-Markopoulou; John Markopoulos
Journal:  Bioinorg Chem Appl       Date:  2009-02-03       Impact factor: 7.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.